Blog

What’s in a name? Plenty when it’s about stem cells – Business Line


Business Line

What's in a name? Plenty when it's about stem cells
Business Line
Closer home, April also saw the Union Health Ministry come out with a draft notification clarifying the definition of stem cells or cell-based products as drugs. It would be classified a drug if the cells were processed, altered or put through “more
Stem Cell Training Signs Agreement to Provide Onsite Regenerative Medicine Training WorldwideDigital Journal


Global Human Embryonic Stem Cell Market Size 2018 Share- (StemCells, Asterias Biotherapeutics, ReNeuron Limited)satPRnews (press release)
Global Fetal Stem Cells Market Size 2018 Share- (STEMCELL Technologies, Axol Bio, Thermo Fisher Scientific)The Mobile Herald
Pharmaceuticals News
all 14 news articles »

2018-04-27 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.